Transcranial Photobiomodulation for Bipolar Depression

Starting soon · Not applicable · Has a placebo group

Conditions studied: Bipolar, Bipolar Disorder (BD), Bipolar Disorder Depression

In brief

This study the effectiveness and safety of light therapy device targeted at the brain using a wearable device, the Vielight RX Gamma as a treatment for bipolar depression. Up to forty patients with bipolar disorder will be enrolled into the study and will either receive active treatment with the Vielight RX Gamma or sham (inactive device). They will be administered the devices in clinic 5days/week for 6 weeks. Changes in disease symptoms, cognitive function, pain, quality of life and rest EEG changes will be assessed.

Key facts

Study ID
NCT07510646
Run by
Vielight Inc.
People needed
40
Starts
2026-07-01
Expected to finish
2027-07-01
Last updated by the study team
2026-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.